




















Carbohydrates are the primordial source of energy and 
carbon for certain unicellular organisms as well as for 
the complex mammalian brain and its synaptic 
functions [1]. However, for all these cells the 
degradation of carbohydrates poses several problems, 
e.g. the formation of toxic by-products such as the 
glycating electrophile methylglyoxal (MG, also named 
2-oxo-propanal) or the excessive generation of lactic 
acid with ensuing pH change [2]. Under conditions of 
high carbon flux and under limited availability of 
NAD+, e.g. during anaerobic glycolysis [3], the triose 
phosphates dihydroxyacetone phosphate and 
glyceraldehyde-3-phosphate spontaneously decompose 
to MG, a compound known to contribute to the 
generation of advanced glycation endproducts (AGEs) 
[4] - with possibly irreversible damage to lipids, nucleic 
acids and proteins, in particular of mitochondria  [5] - 
and to the induction of ubiquitin conjugates [6]. In a 
pathway with very high conservation during evolution, 
all these cells use the enzyme glyoxalase I 
(lactoylglutathione lyase) in the presence of glutathione 
(GSH) to convert MG into S-lactoyl-glutathione (SLG) 
and then use glyoxalase II (hydroxyacylglutathione 
hydrolase) to liberate D-lactate and glutathione. In spite 
of this toxicity of MG, some bacteria use the enzyme 
methylglyoxal synthase to generate MG, apparently to 
regulate carbon flux and growth rate [7]. Furthermore, 
the ratio between GSH and SLG in such bacteria 
modulates potassium efflux and intracellular 
acidification [8]. Acting as a signal initiator, MG 
activates the osmosensor Sln1, the HOG-MAP kinase 
cascade and the calcium(2+) signalling pathway in yeast 























proliferative effect in cancerous cells with enhanced 
glycolysis (Warburg-effect) [10, 11]. MG was recently 
reported to play a physiological role in the modulation 
of hypoxia-induced-factor-1α (HIF-1alpha) levels and 
thus in the modulation of the balance between anaerobic 
and aerobic bioenergetics [12]. Interestingly, an 
anxiety-suppressing effect of MG infusions into the 
brain was observed in mice [13]. And in patients with 
hereditary dyskinesias, episodic disorders of 
spontaneous movement, it is now known that either 
defects in the cerebral glucose transport or defects in the 
putative neuronal SLG sensor protein MR-1 can be 
responsible for these symptoms  [14, 15]. These 
observations suggest that MG and SLG are not simply 
toxic by-products to be eliminated, but might play an 
important physiological function in bioenergetic 
signaling. 
 
In view of the importance of bioenergetics, sugar 
stress and growth pathways for the molecular 
mechanisms of aging, it is hardly surprising that 
mutations in the glyoxalase pathway affect the survival 
under carbonyl stress and adverse growth conditions. 
A stress-protection effect of glyoxalase I overe-
xpression or a sensitizing effect of glyoxalase I 
deficiency was alredy documented in the bacteria 
Escherichia coli under anaerobic conditions with high 
carbon flux [16], the protozoan parasite Leishmania 
donovani [17], in the yeast Saccharomyces cerevisiae 
[18], in the plant Nicotiana tabacum [19, 20], in the 
worm  Caenorhabditis elegans [21] and in Rattus 
norvegicus and Homo sapiens under diabetic sugar 
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glyoxalase I, since this enzyme catalyzes the rate-
limiting step in the pathway. Furthermore, glyoxalase I 
is regulated in its expression on the transcript level. 
Elevated mRNA / protein levels or increased enzyme 
activity were found to mediate the survival of dental 
caries bacteria Streptococcus mutans and their 
continued maintenance of glycolysis in media with 
high sugar and acid concentrations [24, 25], of 
Bacillus anthracis, of the fungus Candida albicans and 
of the worm Onchocerca volvulus under oxidative 
stress [26-28], of Arabidopsis thaliana under abiotic 
stress [29], of the high-dormancy seeds of the grass 
Lolium rigidum Gaud [30], of rice Oryza sativa roots 
under chilling temperatures or leaves under UV 
radiation [31, 32], of the tomato Solanum 
pimpinellifolium as well as the mustard Brassica 
juncea under salt and heavy metal stress [33, 34] and 
of mammalian cancer cells under stress [35]. However, 
it is has remained unclear whether increased 
glyoxalase I levels only serve to protect normal growth 
and survival under adverse conditions, or whether they 
are able to postpone aging and increase health at 
advanced age, as a means to longevity. 
 
Therefore, the recent publication in AGING from 
investigators around H. Osiewacz in Frankfurt [36] is 
therefore very important, assessing the relevance of the 
glyoxalase pathway for growth and lifespan in a model 
organism that has been very well characterized for more 
than 50 years within the field of healthy aging organism 
research, namely the fungus Podospora anserina [37]. 
This filamentous ascomycete thrives under aerobic 
conditions and on extracellular glucose, completing a 
life cycle of germination, maturity with maximal 
growth, senescence with pigmentation and apical cell 
death within three weeks. Here, the principal finding of 
the authors was the extension of the healthy lifespan by 
4.3% through the combined overexpression of 
glyoxalase I + II under conditions of sugar stress (2% 
glucose), while no lifespan differences were apparent 
for normal sugar concentrations. No growth differences 
were apparent under any conditions tested. Importantly 
and unexpectedly, this study found a reduction of 
lifespan through strong overexpression of glyoxalase I 
alone, in contrast to a report of enhanced lifespan after 
mild glyoxalase I overexpression in C. elegans [21], 
suggesting that overly strong glyoxalase activity may be 
toxic due to glutathione depletion with subsequent 
oxidative stress and possibly potassium efflux. Together 
with three crucial previous publications from the same 
team [38-42], these data indicate that a prolongation of 
healthspan  is   possible  through  a  network  of  factors  
 
 
controlling aerobic and anaerobic bioenergetics. 
 
Indeed, these data are of paramount importance for the 
needs of our modern civilization characterized by 
excess sugar consumption and an ever older population. 
They are also a sound scientific basis for future 
molecular understanding of human aging, where the 
glyoxalase system has been implicated in senescence 
and in several age-related disorders. In man, where the 
promoter of gloxalase I is inducible by insulin and 
heavy metals [43], the transcript levels of glyoxalase I 
show a continuous decrease after the start of senescence 
at 55 years of age, similar to the decrease of glyoxalase 
I levels in old rat muscle tissue [44, 45]. As a biomarker 
of anxiety, altered expression levels of glyoxalase I 
were reported in mice, compatible with the hypothesis 
that low MG levels correlate with anxiety, and an 
anxiolytic effect of MG infusions into brain was 
demonstrated [13, 46-49]. Glyoxalase I anomalies were 
also reported in psychiatric diseases such as mood 
disorder, schizophrenia and autism, where anxiety 
symptoms are altered [50-52]. As a biomarker of tau 
protein pathology in Alzheimer’s disease and 
frontotemporal dementia, increased expression of 
glyoxalase I was reported in mouse models and patients, 
and tau aggregation was observed as an effect of 
elevated MG levels [53-55]. With tau and alpha-
synuclein being the two most important genetic risk 
factors of Parkinson’s disease (PD) [56] and in view of 
the co-precipitation of these two proteins in the 
pathognomonic cytoplasmic “Lewy body” inclusions 
[57, 58], it is interesting that we found an upregulation 
of glyoxalase I to be the prominent response within the 
mouse brain transcriptome to a deficient alpha-
synuclein function [59]. Whether a gain-of-function of 
alpha-synuclein and other Parkinson triggering events 
also modulate the glyoxalase system, remains an issue 
we are investigating, and this seems credible in view of 
a report on altered glyoxalase I expression in mouse 
brains with Parkin deficiency [60]. Furthermore, an 
unexplained glutathione depletion and the presence of 
AGEs in brain autopsies with incidental Lewy bodies 
[61, 62] suggests an involvement of this pathway in the 
earliest stages of PD pathogenesis. 
 
Since pharmacological tools are available to selectively 
antagonize glyoxalase I function [10, 11, 63] and to 
relieve carbonyl stress [64-67], it is now very promising 
to have the mutants generated in this publication of 
AGING [36] as a fast and well-characterized micro-
organism model of age-related neurodegenerative 
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